Table 3.
Adverse Event | Risedronate N (%) |
Placebo N (%) |
P-value |
---|---|---|---|
Breast related | 5 (9) | 4 (7) | 1.00 |
Gastrointestinal | 4 (7) | 13 (24) | 0.019 |
Cardiovascular | 8 (14) | 11 (20) | 0.459 |
Respiratory | 4(7) | 10(18) | 0.093 |
Musculoskeletal | 27 (49) | 33 (61) | 0.250 |
Serious | 10 (18) | 16 (30) | 0.183 |
Nonserious | 52(95) | 50(93) | 0.716 |